ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Long-Term Evaluation of NT-Probnp Levels in Ankylosing Spondylitis Patients Under TNF Blockers: A Marker of Persistent Disease Activity? (2014)
Russo, Debora; Saad, Carla G. S.; Ribeiro, Ana C. M.; Goldeinstein-Schainberg, Claudia; Sampaio-Barros, Percival D.; Goncalves, Celio R.; Bonfa, Eloisa; Moraes, Julio C. B.
Source: Arthritis and rheumatism. Conference titles: ACR/ARHP Annual Meeting. Unidade: FM
Subjects: ESPONDILITE ANQUILOSANTE, PEPTÍDEOS, BIOMARCADORES, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUSSO, Debora et al. Long-Term Evaluation of NT-Probnp Levels in Ankylosing Spondylitis Patients Under TNF Blockers: A Marker of Persistent Disease Activity?. Arthritis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/art.v66.S10/issuetoc. Acesso em: 06 nov. 2024. , 2014
APA
Russo, D., Saad, C. G. S., Ribeiro, A. C. M., Goldeinstein-Schainberg, C., Sampaio-Barros, P. D., Goncalves, C. R., et al. (2014). Long-Term Evaluation of NT-Probnp Levels in Ankylosing Spondylitis Patients Under TNF Blockers: A Marker of Persistent Disease Activity? Arthritis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1002/art.v66.S10/issuetoc
NLM
Russo D, Saad CGS, Ribeiro ACM, Goldeinstein-Schainberg C, Sampaio-Barros PD, Goncalves CR, Bonfa E, Moraes JCB. Long-Term Evaluation of NT-Probnp Levels in Ankylosing Spondylitis Patients Under TNF Blockers: A Marker of Persistent Disease Activity? [Internet]. Arthritis and rheumatism. 2014 ; 66( S10): S426.[citado 2024 nov. 06 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.v66.S10/issuetoc
Vancouver
Russo D, Saad CGS, Ribeiro ACM, Goldeinstein-Schainberg C, Sampaio-Barros PD, Goncalves CR, Bonfa E, Moraes JCB. Long-Term Evaluation of NT-Probnp Levels in Ankylosing Spondylitis Patients Under TNF Blockers: A Marker of Persistent Disease Activity? [Internet]. Arthritis and rheumatism. 2014 ; 66( S10): S426.[citado 2024 nov. 06 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.v66.S10/issuetoc
Artigo de periodico
Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? (2012)
Saad, Carla G. S.; Ribeiro, Ana C. M.; Moraes, Julio C. B.; Takayama, Liliam; Goncalves, Celio R.; Rodrigues, Marcelo B.; Oliveira, Ricardo M. de; Silva, Clovis A.; Bonfa, Eloisa; Pereira, Rosa M. R.
Source: Arthritis research & therapy. Unidade: FM
Subjects: NECROSE, BIOMARCADORES, INFLAMAÇÃO (PARÂMETROS), ESPONDILITE ANQUILOSANTE, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAAD, Carla G. S. et al. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?. Arthritis research & therapy, v. 14, n. 5, p. (online), 2012Tradução . . Disponível em: http://arthritis-research.com/content/pdf/ar4055.pdf. Acesso em: 06 nov. 2024.
APA
Saad, C. G. S., Ribeiro, A. C. M., Moraes, J. C. B., Takayama, L., Goncalves, C. R., Rodrigues, M. B., et al. (2012). Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? Arthritis research & therapy, 14( 5), (online). doi:10.1186/ar4055
NLM
Saad CGS, Ribeiro ACM, Moraes JCB, Takayama L, Goncalves CR, Rodrigues MB, Oliveira RM de, Silva CA, Bonfa E, Pereira RMR. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? [Internet]. Arthritis research & therapy. 2012 ; 14( 5): (online).[citado 2024 nov. 06 ] Available from: http://arthritis-research.com/content/pdf/ar4055.pdf
Vancouver
Saad CGS, Ribeiro ACM, Moraes JCB, Takayama L, Goncalves CR, Rodrigues MB, Oliveira RM de, Silva CA, Bonfa E, Pereira RMR. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? [Internet]. Arthritis research & therapy. 2012 ; 14( 5): (online).[citado 2024 nov. 06 ] Available from: http://arthritis-research.com/content/pdf/ar4055.pdf
Artigo de periodico
Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy? (2012)
Borba, Eduardo F.; Saad, Carla G. S.; Pasoto, Sandra G.; Calich, Ana L. G.; Aikawa, Nadia E.; Ribeiro, Ana C. M.; Moraes, Julio C. B.; Leon, Elaine P.; Costa, Luciana P.; Guedes, Lissiane K. N.; Silva, Clovis A. A.; Goncalves, Celio R.; Fuller, Ricardo; Oliveira, Suzimara A.; Ishida, Maria A.; Precioso, Alexander R.; Bonfa, Eloisa
Source: Rheumatology. Unidade: FM
Subjects: FÁRMACOS IMUNOSSUPRESSORES (USO TERAPÊUTICO), VACINAS VIRAIS (IMUNOLOGIA), INFLUENZA (IMUNOLOGIA), VACINAÇÃO, LÚPUS ERITEMATOSO SISTÊMICO (IMUNOLOGIA), ANTIMALÁRICOS (APLICAÇÕES TERAPÊUTICAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORBA, Eduardo F. et al. Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?. Rheumatology, v. 51, n. 6, p. 1061-1069, 2012Tradução . . Disponível em: https://doi.org/10.1093/rheumatology/ker427. Acesso em: 06 nov. 2024.
APA
Borba, E. F., Saad, C. G. S., Pasoto, S. G., Calich, A. L. G., Aikawa, N. E., Ribeiro, A. C. M., et al. (2012). Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy? Rheumatology, 51( 6), 1061-1069. doi:10.1093/rheumatology/ker427
NLM
Borba EF, Saad CGS, Pasoto SG, Calich ALG, Aikawa NE, Ribeiro ACM, Moraes JCB, Leon EP, Costa LP, Guedes LKN, Silva CAA, Goncalves CR, Fuller R, Oliveira SA, Ishida MA, Precioso AR, Bonfa E. Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy? [Internet]. Rheumatology. 2012 ; 51( 6): 1061-1069.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1093/rheumatology/ker427
Vancouver
Borba EF, Saad CGS, Pasoto SG, Calich ALG, Aikawa NE, Ribeiro ACM, Moraes JCB, Leon EP, Costa LP, Guedes LKN, Silva CAA, Goncalves CR, Fuller R, Oliveira SA, Ishida MA, Precioso AR, Bonfa E. Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy? [Internet]. Rheumatology. 2012 ; 51( 6): 1061-1069.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1093/rheumatology/ker427
Artigo de periodico
Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice (2011)
Ribeiro, Ana C. M.; Guedes, Lissiane K. N.; Moraes, Julio C. B.; Saad, Carla G. S.; Aikawa, Nadia E.; Calich, Ana Luisa; França, Ivan L. A.; Carvalho, Jozelio F.; Sampaio-Barros, Percival D.; Goncalves, Celio R.; Borba, Eduardo F.; Timenetsky, Maria do Carmo S.; Precioso, Alexander R.; Duarte, Alberto; Bonfa, Eloisa; Laurindo, Ieda M. M.
Source: Annals of the Rheumatic Diseses. Unidades: FM, HU
Subjects: INFLUENZA (IMUNOLOGIA), PRÁTICA PROFISSIONAL, ARTRITE REUMATOIDE (IMUNOLOGIA), VACINAÇÃO (PREVENÇÃO E CONTROLE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Ana C. M. et al. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice. Annals of the Rheumatic Diseses, v. 70, n. 12, p. 2144-2147, 2011Tradução . . Disponível em: https://doi.org/10.1136/ard.2011.152983. Acesso em: 06 nov. 2024.
APA
Ribeiro, A. C. M., Guedes, L. K. N., Moraes, J. C. B., Saad, C. G. S., Aikawa, N. E., Calich, A. L., et al. (2011). Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice. Annals of the Rheumatic Diseses, 70( 12), 2144-2147. doi:10.1136/ard.2011.152983
NLM
Ribeiro ACM, Guedes LKN, Moraes JCB, Saad CGS, Aikawa NE, Calich AL, França ILA, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky M do CS, Precioso AR, Duarte A, Bonfa E, Laurindo IMM. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice [Internet]. Annals of the Rheumatic Diseses. 2011 ; 70( 12): 2144-2147.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1136/ard.2011.152983
Vancouver
Ribeiro ACM, Guedes LKN, Moraes JCB, Saad CGS, Aikawa NE, Calich AL, França ILA, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky M do CS, Precioso AR, Duarte A, Bonfa E, Laurindo IMM. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice [Internet]. Annals of the Rheumatic Diseses. 2011 ; 70( 12): 2144-2147.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1136/ard.2011.152983
Artigo de periodico
Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases (2011)
Saad, Carla G. S.; Borba, Eduardo F.; Aikawa, Nadia E.; Silva, Clovis A.; Pereira, Rosa M. R.; Calich, Ana Luisa; Moraes, Julio C. B.; Ribeiro, Ana C. M.; Viana, Vilma S. T.; Pasoto, Sandra G.; Carvalho, Jozelio F.; França, Ivan L. A.; Guedes, Lissiane K. N.; Shinjo, Samuel K.; Sampaio-Barros, Percival D.; Caleiro, Maria T.; Goncalves, Celio R.; Fuller, Ricardo; Levy-Neto, Mauricio; Timenetsky, Maria do Carmo S.; Precioso, Alexander R.; Bonfa, Eloisa
Source: Annals of the Rheumatic Diseses. Unidade: FM
Subjects: DOENÇAS REUMÁTICAS (IMUNOLOGIA), VACINAS VIRAIS (IMUNOLOGIA), INFLUENZA (IMUNOLOGIA), DOENÇAS NEUROMUSCULARES, IMUNOLOGIA CLÍNICA, AUTOIMUNIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAAD, Carla G. S. et al. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases. Annals of the Rheumatic Diseses, v. 70, n. 7, p. 1068-1073, 2011Tradução . . Disponível em: https://doi.org/10.1136/ard.2011.150250. Acesso em: 06 nov. 2024.
APA
Saad, C. G. S., Borba, E. F., Aikawa, N. E., Silva, C. A., Pereira, R. M. R., Calich, A. L., et al. (2011). Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases. Annals of the Rheumatic Diseses, 70( 7), 1068-1073. doi:10.1136/ard.2011.150250
NLM
Saad CGS, Borba EF, Aikawa NE, Silva CA, Pereira RMR, Calich AL, Moraes JCB, Ribeiro ACM, Viana VST, Pasoto SG, Carvalho JF, França ILA, Guedes LKN, Shinjo SK, Sampaio-Barros PD, Caleiro MT, Goncalves CR, Fuller R, Levy-Neto M, Timenetsky M do CS, Precioso AR, Bonfa E. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases [Internet]. Annals of the Rheumatic Diseses. 2011 ; 70( 7): 1068-1073.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1136/ard.2011.150250
Vancouver
Saad CGS, Borba EF, Aikawa NE, Silva CA, Pereira RMR, Calich AL, Moraes JCB, Ribeiro ACM, Viana VST, Pasoto SG, Carvalho JF, França ILA, Guedes LKN, Shinjo SK, Sampaio-Barros PD, Caleiro MT, Goncalves CR, Fuller R, Levy-Neto M, Timenetsky M do CS, Precioso AR, Bonfa E. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases [Internet]. Annals of the Rheumatic Diseses. 2011 ; 70( 7): 1068-1073.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1136/ard.2011.150250

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em